World Trade Organization Organisation Mondiale du Commerce Organización Mundial del Comercio


It is necessary to provide pricing and other proprietary information on medical devices to protect the interest of consumers



Yüklə 1,35 Mb.
səhifə470/486
tarix03.01.2022
ölçüsü1,35 Mb.
#37174
1   ...   466   467   468   469   470   471   472   473   ...   486
It is necessary to provide pricing and other proprietary information on medical devices to protect the interest of consumers.

US 63:

Report by the Secretariat (WT/TPR/S/249): III. TRADE POLICIES AND PRACTICES BY MEASURE: (2) Measures Directly Affecting Imports: (x) Sanitary and phytosanitary measures (SPS): Page 71, paragraph 115:

The Secretariat report states that "Currently there is no mandatory labelling requirement for genetically modified (GM) products. However, legislation is in the pipeline: The Ministry of Health and Family Welfare has proposed comprehensive labelling requirements for GM foods, requiring all packages of food/food ingredients of GM origin, that are subject to the approval of the Genetic Engineering Approval Committee (GEAC), to bear a label indicating that they are of GM origin, and that the product has been cleared for sale in the exporting country." Given the broad definition of biotech enhanced food under the proposed legislation, what is India's rationale for requiring biotechnology labelling, as the end product may not even contain genetically engineered material? If such a justification is on the basis of supporting "informed consumer choice," what meaningful information regarding the composition, safety, or special handling requirements for the foods will the mandatory labelling requirement convey? How does India propose to enforce such a requirement?


Yüklə 1,35 Mb.

Dostları ilə paylaş:
1   ...   466   467   468   469   470   471   472   473   ...   486




Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur ©muhaz.org 2024
rəhbərliyinə müraciət

gir | qeydiyyatdan keç
    Ana səhifə


yükləyin